Anixa Biosciences (ANIX) Prepaid Assets (2010 - 2026)
Anixa Biosciences' (ANIX) quarterly Prepaid Assets came in at $950000.0 in Q2 2026, down 18.73% YoY from $1.2 million in Q2 2025, and up 33.24% on a QoQ basis from $713000.0 in Q4 2025.
Anixa Biosciences (ANIX) Prepaid Assets (2010 - 2026) Analysis & Trends
Anixa Biosciences (ANIX) has 17 years of Prepaid Assets data on file, last reported at $950000.0 in Q2 2026.
- Quarterly Prepaid Assets fell 18.73% year-over-year to $950000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $950000.0 (down 18.73% YoY) and the FY2025 annual result came in at $713000.0, down 43.64% from the prior year.
- Prepaid Assets climbed to $950000.0 in Q2 2026, from $713000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q3 2024 to a low of $178000.0 in Q2 2023.
- A 5-year average of $846882.4 and a median of $757000.0 in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets tumbled 46.39% — and 2024, when it soared 325.28%.
- Tracing ANIX's Prepaid Assets over 5 years: stood at $467000.0 in 2022, then jumped by 165.95% to $1.2 million in 2023, then advanced by 1.85% to $1.3 million in 2024, then sank by 43.64% to $713000.0 in 2025, then surged by 33.24% to $950000.0 in 2026.
- The last three Prepaid Assets figures came in at $950000.0 (Q2 2026), $713000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Anixa Biosciences | 123.62 Mn | 123.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 950,000.00 |
| Oct 31, 2025 | 713,000.00 |
| Jul 31, 2025 | 1.42 Mn |
| Apr 30, 2025 | 1.17 Mn |
| Jan 31, 2025 | 1.43 Mn |
| Oct 31, 2024 | 1.27 Mn |
| Jul 31, 2024 | 1.52 Mn |
| Apr 30, 2024 | 757,000.00 |
| Jan 31, 2024 | 1.03 Mn |
| Oct 31, 2023 | 1.24 Mn |
| Jul 31, 2023 | 532,000.00 |
| Apr 30, 2023 | 178,000.00 |
| Jan 31, 2023 | 256,000.00 |
| Oct 31, 2022 | 467,000.00 |
| Jul 31, 2022 | 676,000.00 |
| Apr 30, 2022 | 332,000.00 |
| Jan 31, 2022 | 464,000.00 |
| Oct 31, 2021 | 276,000.00 |
| Jul 31, 2021 | 430,006.00 |
| Apr 30, 2021 | 369,213.00 |